Global Tuberculosis Report -- 2012.pdf

More documents

Recommendations

Info

EUROPEAN REGIONTable A4.1 Estimates of the burden of disease caused by TB, 1990–2011 213Table A4.2 Incidence, notification and case detection rates, all forms, 1990–2011 217Table A4.3 Case notifi cations, 1990–2011 221Table A4.4 Treatment outcomes, new smear-positive cases, 1995–2010 225Table A4.5 Treatment outcomes, retreatment cases, 1995–2010 228Table A4.6 HIV testing and provision of CPT, ART and IPT, 2005–2011 231Table A4.7 Testing for MDR-TB and number of confi rmed cases of MDR-TB, 2005–2011 233Table A4.8 New smear-positive case notifi cation by age and sex, 1995–2011 235Table A4.9 Laboratories, NTP services, drug management and infection control, 2011 238
Estimates of mortality, prevalence and incidenceEstimated values are shown as best estimates followed by lower and upper bounds. The lower and upper bounds aredefined as the 2.5th and 97.5th centiles of outcome distributions produced in simulations. See Annex 1 for furtherdetails.Estimated numbers are shown rounded to two significant figures. Estimated rates are shown rounded to three significantfigures unless the value is under 100, in which case rates are shown rounded to two significant figures. Blank cellsindicate that estimates are not available.Estimates for all years are recalculated as new information becomes available and techniques are refined, so they maydiffer from those published in previous reports in this series. Estimates published in previous global TB control reportsshould no longer be used.Data sourceData shown in this annex are taken from the WHO global TB database on 25 September 2012. Data shown in the mainpart of the report were taken from the database in July 2012. As a result, data in this annex may differ slightly fromthose in the main part of the report.Data can be downloaded from www.who.int/tb/data.Country notesEU/EEA countriesNotification and treatment outcome data for European Union and European Economic Area countries are provision al.DenmarkData for Denmark exclude Greenland.Russian Federation<strong>Report</strong>ed number of TB patients with known HIV status in Table A4.6 is for new TB patients only in 2010 and 2011. Itwas not possible to calculate the % of all TB patients with known HIV status.212 Data can be downloaded from www.who.int/tb/data GLOBAL TUBERCULOSIS REPORT 2012
Page 2 and 3:
GLOBALTUBERCULOSISREPORT2012
Page 4 and 5:
ContentsAbbreviationsivAcknowledgem
Page 6 and 7:
AcknowledgementsThis report on glob
Page 8 and 9:
WHO Western Pacific RegionShalala A
Page 10 and 11:
Executive SummaryThe World Health O
Page 12 and 13:
CHAPTER 1IntroductionBOX 1.1Basic f
Page 14 and 15:
TABLE 1.1 Targets for the scale-up
Page 16 and 17:
TABLE 1.2 Reporting of data in the
Page 18 and 19:
BOX 2.1Uncertainty in estimates of
Page 20 and 21:
TABLE 2.2 Estimated burden of disea
Page 22 and 23:
FIGURE 2.5 Estimated TB incidence r
Page 24 and 25:
FIGURE B2.2.1Reporting of notificat
Page 26 and 27:
FIGURE 2.8Estimated TB incidence ra
Page 28 and 29:
FIGURE 2.11 Countries (in blue) for
Page 30 and 31:
FIGURE 2.12 Trends in estimated TB
Page 32 and 33:
● producing and widely disseminat
Page 34 and 35:
FIGURE 2.16 Progress in global cove
Page 36 and 37:
BOX 2.6Efforts by the Task Force to
Page 38 and 39:
CHAPTER 3TB case notificationsand t
Page 40 and 41:
BOX 3.1 1Definitions of TB casesDef
Page 42 and 43:
TABLE 3.3 Contribution of public-pr
Page 44 and 45:
BOX 3.4Integrating community-based
Page 46 and 47:
TABLE 3.4 Estimates of the case det
Page 48 and 49:
TABLE 3.5 Treatment success for new
Page 50 and 51:
CHAPTER 4Drug-resistant TBKEY FACTS
Page 52 and 53:
FIGURE 4.2 Percentage of new TB cas
Page 54 and 55:
BOX 4.1Frequencies of resistance to
Page 56 and 57:
FIGURE 4.6 Number of MDR-TB cases e
Page 58 and 59:
FIGURE 4.7Notified cases of MDR-TB
Page 60 and 61:
egimens globally, providing more su
Page 62 and 63:
5.1 Funding for TB care and control
Page 64 and 65:
TABLE 5.2 NTP budgets, available fu
Page 66 and 67:
FIGURE 5.5Trends in domestic and do
Page 68 and 69:
FIGURE 5.6Domestic funding as a per
Page 70 and 71:
FIGURE 5.8Cost per TB patient succe
Page 72 and 73:
FIGURE 5.10 Total cost and unit cos
Page 74 and 75:
● The 14 countries not included i
Page 76 and 77:
on public health by an external Exp
Page 78 and 79:
evised as a result of the introduct
Page 80 and 81:
TABLE 6.2 Incorporation of WHO poli
Page 82 and 83:
FIGURE 6.3The Supranational Referen
Page 84 and 85:
of TB disease by 65%, irrespective
Page 86 and 87:
FIGURE 7.3Percentage of TB patients
Page 88 and 89:
BOX 7.1Accelerating progress in pro
Page 90 and 91:
TABLE 7.2 Assumptions used to estim
Page 92 and 93:
FIGURE 8.1 The development pipeline
Page 94 and 95:
sputum specimens and TB isolates fr
Page 96 and 97:
cal trial sites and building labora
Page 98:
new TB vaccine candidate. A Phase I
Page 102 and 103:
This annex explains the methods tha
Page 104 and 105:
2011. On average, 15 data points we
Page 106 and 107:
may suffer from biases. These biase
Page 108 and 109:
TABLE A1.3Parameter estimates used
Page 110 and 111:
5. Estimates of TB prevalence, 1990
Page 112:
the Republic of Moldova, Romania, t
Page 116 and 117:
AFGHANISTANPopulation 2011 32 milli
Page 118 and 119:
BRAZILPopulation 2011 197 millionHI
Page 120 and 121:
CHINAPopulation 2011 1 348 millionH
Page 122 and 123:
ETHIOPIAPopulation 2011 85 millionH
Page 124 and 125:
INDONESIAPopulation 2011 242 millio
Page 126 and 127:
MOZAMBIQUEPopulation 2011 24 millio
Page 128 and 129:
NIGERIAPopulation 2011 162 millionH
Page 130 and 131:
PHILIPPINESPopulation 2011 95 milli
Page 132 and 133:
SOUTH AFRICAPopulation 2011 50 mill
Page 134 and 135:
UGANDAPopulation 2011 35 millionHIG
Page 136 and 137:
VIET NAMPopulation 2011 89 millionH
Page 138:
ANNEX 3Regional profiles
Page 141 and 142:
WHO REGION OF THE AMERICASPopulatio
Page 143 and 144:
WHO EUROPEAN REGIONPopulation 2011
Page 145 and 146:
WHO WESTERN PACIFIC REGIONPopulatio
Page 148 and 149:
SUMMARY BY WHO REGIONTable A4.1 Est
Page 150 and 151:
MORTALITY (EXCLUDING HIV) PREVALENC
Page 152 and 153:
NEW AND RELAPSENOTIFICATION RATE aY
Page 154 and 155:
-% OF TB PATIENTS WITHKNOWN HIV STA
Page 156 and 157:
AFRICAN REGIONTable A4.1 Estimates
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
INCIDENCE (INCLUDING HIV) INCIDENCE
Page 164 and 165:
NEW AND RELAPSENOTIFICATION RATE aY
Page 166 and 167:
NEW AND RELAPSENOTIFICATION RATE a1
Page 168 and 169:
TREATMENT SUCCESS (%) a1995-2010YEA
Page 170 and 171: TREATMENT SUCCESS (%) a1995-2010YEA
Page 172 and 173: TREATMENT SUCCESS (%) a1995-2010YEA
Page 174 and 175: -% OF TB PATIENTS WITHKNOWN HIV STA
Page 176 and 177: YEARTOTALCONFIRMEDCASES OFMDR-TB aE
Page 178 and 179: MALEYEAR 0-14 15-24 25-34 35-44 45-
Page 180 and 181: REGION OF THE AMERICASTable A4.1 Es
Page 182 and 183: MORTALITY (EXCLUDING HIV) PREVALENC
Page 186 and 187: INCIDENCE (INCLUDING HIV) INCIDENCE
Page 188 and 189: NEW AND RELAPSENOTIFICATION RATE a1
Page 192 and 193: % OF COHORTTREATMENT SUCCESS (%) a1
Page 202 and 203: MALEFEMALEYEAR 0-14 15-24 25-34 35-
Page 204 and 205: EASTERN MEDITERRANEAN REGIONTable A
Page 248 and 249: SOUTH-EAST ASIA REGIONTable A4.1 Es
Page 258: SMEAR LABS % OF SMEARPER 100K LABS
Page 261 and 262: Estimates of mortality, prevalence
Page 263 and 264: YEARPOPULATION(MILLIONS)MORTALITY (
Page 265 and 266: YEARPOPULATION(MILLIONS)INCIDENCE (
Page 267 and 268: YEARPOPULATION(MILLIONS)INCIDENCE (
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
-% OF TB PATIENTS WITHKNOWN HIV STA
Page 277 and 278:
YEARTOTALCONFIRMEDCASES OFMDR-TB aE
Page 279 and 280:
MALEFEMALEYEAR 0-14 15-24 25-34 35-
Page 281 and 282:
SMEAR LABS % OF SMEARPER 100K LABS
show all

Global Tuberculosis Report -- 2012.pdf

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?